Novartis Considers Animal Health Unit Sale in Asset Review

Nov 07, 2013

Bloomberg.com

Inside sources are reporting that Novartis AG has identified its animal-health business as a top candidate for a sale. Novartis is also considering selling its over-the-counter medicines unit and the vaccines operation, sources said.

Novartis is in the early stages of a portfolio review with Goldman Sachs Group.

Novartis currently has five units: the Alcon eye-care business; pharmaceuticals; vaccines and diagnostics; the Sandoz generic-medicines division; and consumer health, which includes both over-the-counter medicines and animal-health products.

Read the Bloomberg release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments